Lupin recently said it has received approval from the US health regulator to market Doxycycline capsules used to treat bacterial infections in the American market, Lupin said in a statement.
The drug firm has received tentative approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline capsules, 40 mg, a generic equivalent of Galderma Laboratories’ Oracea capsules, the statement added.
Edits by EP News Bureau
thanks for sharing !!!!!!!!